Thursday, March 30, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Disclosures for additional planners can be found here.
General Practitioner
Clinical Director, Patient.info
London, United Kingdom
Professor of Experimental Medicine
National Heart and Lung Institute
Imperial College London
London, United Kingdom
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Posted: 30/11/2022
This activity is intended for European primary care physicians, infectious disease specialists, internal medicine specialists, pharmacists, and nurses.
The goal of this activity is for learners to gain knowledge on the principles of bivalent booster vaccines and understand why booster vaccines are needed in the current COVID-19 pandemic.
Upon completion of this activity, participants will be able to:
The goal of this activity is for learners to gain knowledge on the principles of bivalent booster vaccines and understand why booster vaccines are needed in the current COVID-19 pandemic.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
